BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 36732586)

  • 1. The neurobiology of irritable bowel syndrome.
    Mayer EA; Ryu HJ; Bhatt RR
    Mol Psychiatry; 2023 Apr; 28(4):1451-1465. PubMed ID: 36732586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a systems view of IBS.
    Mayer EA; Labus JS; Tillisch K; Cole SW; Baldi P
    Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):592-605. PubMed ID: 26303675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable Bowel Syndrome: A Clinical Review.
    Cashman MD; Martin DK; Dhillon S; Puli SR
    Curr Rheumatol Rev; 2016; 12(1):13-26. PubMed ID: 26717952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.
    Crowell MD; Harris L; Jones MP; Chang L
    Curr Gastroenterol Rep; 2005 Aug; 7(4):272-9. PubMed ID: 16042910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers.
    Moshiree B; Heidelbaugh JJ; Sayuk GS
    Adv Ther; 2022 Sep; 39(9):4003-4020. PubMed ID: 35869354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the pathogenesis and treatment of irritable bowel syndrome.
    Oświęcimska J; Szymlak A; Roczniak W; Girczys-Połedniok K; Kwiecień J
    Adv Med Sci; 2017 Mar; 62(1):17-30. PubMed ID: 28135659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review.
    Shaikh SD; Sun N; Canakis A; Park WY; Weber HC
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ
    Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead.
    Shin A; Kashyap PC
    Gut Microbes; 2023; 15(1):2195792. PubMed ID: 37009874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.
    Camilleri M; Ford AC
    Handb Exp Pharmacol; 2017; 239():75-113. PubMed ID: 27995391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome.
    Keszthelyi D; Troost FJ; Masclee AA
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(2):G141-54. PubMed ID: 22595988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome: update on pathogenesis and management.
    Alaradi O; Barkin JS
    Med Princ Pract; 2002; 11(1):2-17. PubMed ID: 12116690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits.
    Sarnoff RP; Bhatt RR; Osadchiy V; Dong T; Labus JS; Kilpatrick LA; Chen Z; Subramanyam V; Zhang Y; Ellingson BM; Naliboff B; Chang L; Mayer EA; Gupta A
    Neuropharmacology; 2023 Mar; 225():109381. PubMed ID: 36539012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions.
    Tait C; Sayuk GS
    Eur J Intern Med; 2021 Feb; 84():1-9. PubMed ID: 33423906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local immune response as novel disease mechanism underlying abdominal pain in patients with irritable bowel syndrome.
    Aguilera-Lizarraga J; Florens M; Hussein H; Boeckxstaens G
    Acta Clin Belg; 2022 Oct; 77(5):889-896. PubMed ID: 34709996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.
    Stasi C; Bellini M; Bassotti G; Blandizzi C; Milani S
    Tech Coloproctol; 2014 Jul; 18(7):613-21. PubMed ID: 24425100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in pharmacological treatment of irritable bowel syndrome.
    Lazaraki G; Chatzimavroudis G; Katsinelos P
    World J Gastroenterol; 2014 Jul; 20(27):8867-85. PubMed ID: 25083060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.